Net profit of Morepen Laboratories rose 63.92% to Rs 34.85 crore in the quarter ended September 2024 as against Rs 21.26 crore during the previous quarter ended September 2023. Sales rose 3.78% to Rs 437.73 crore in the quarter ended September 2024 as against Rs 421.77 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales437.73421.77 4 OPM %10.077.96 - PBDT47.8836.37 32 PBT46.0228.68 60 NP34.8521.26 64 Powered by Capital Market - Live News

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live News

Morepen Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live News

Morepen Laboratories has appointed Sharad Jain (DIN: 06423452) as an Independent Director, for a term of 5 consecutive years, effective from 27 August 2024. Powered by Capital Market - Live News

Net profit of Morepen Laboratories rose 147.23% to Rs 36.17 crore in the quarter ended June 2024 as against Rs 14.63 crore during the previous quarter ended June 2023. Sales rose 13.51% to Rs 455.22 crore in the quarter ended June 2024 as against Rs 401.04 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales455.22401.04 14 OPM %11.346.51 - PBDT53.8928.23 91 PBT48.1720.51 135 NP36.1714.63 147 Powered by Capital Market - Live News